A Study to Assess the Effects of Zigakibart on IgA Nephropathy. | MicrobiomeTrials← Back to trialsNCT07146906
A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2026-03-26Est. Completion: 2030-07-12
Enrollment target: 32 participants Locations- UC San Francisco Medical Center, San Francisco, California, United States
- Colorado Kidney Care Nephrology, Denver, Colorado, United States
- American Clinical Trials, Acworth, Georgia, United States
- Univ Of Iowa Hospitals And Clinics, Iowa City, Iowa, United States
- Inter Med Consultants, Edina, Minnesota, United States
- Novartis Investigative Site, Serra, Espírito Santo, Brazil
- Novartis Investigative Site, Recife, Pernambuco, Brazil
- Novartis Investigative Site, Natal, Rio Grande do Norte, Brazil
- Novartis Investigative Site, Botucatu, São Paulo, Brazil
- Novartis Investigative Site, Beijing, China
- Novartis Investigative Site, Shanghai, China
- Novartis Investigative Site, Prague, Czechia
- Novartis Investigative Site, Munich, Bavaria, Germany
- Novartis Investigative Site, Hanover, Germany
- Novartis Investigative Site, Mainz, Germany
- Novartis Investigative Site, Ranica, BG, Italy
- Novartis Investigative Site, Brescia, BS, Italy
Other microbiome trials you might be interested in
Kidney Disease
Immunoglobulin A nephropathy (IgAN) is a kidney condition. It happens when the body's immune system creates groups of pr…
Birmingham, United StatesEst. completion Sep 7, 2028
Primary IgA Nephropathy
The goal of this clinical trial is to evaluate if obinutuzumab beta works to treat primary IgA nephropathy with active p…
Shanghai, ChinaEst. completion Jun 30, 2028
Novartis Investigative Site, Pavia, PV, ItalyNovartis Investigative Site, Kawasaki, Kanagawa, JapanNovartis Investigative Site, Miyazaki, JapanNovartis Investigative Site, Lodz, PolandNovartis Investigative Site, Opole, PolandNovartis Investigative Site, Seoul, Seoul, South KoreaNovartis Investigative Site, Seoul, South KoreaNovartis Investigative Site, Pamplona, Navarre, SpainNovartis Investigative Site, Valencia, Valencia, SpainNovartis Investigative Site, Barcelona, SpainNovartis Investigative Site, Seville, SpainNovartis Investigative Site, Kaohsiung City, TaiwanNovartis Investigative Site, Taipei, TaiwanPhase 3
Recruiting
Immunoglobulin A Nephropathy
The purpose of this study is to evaluate participant treatment experience with Povetacicept injection administered via a…
Multiple LocationsEst. completion Dec 12, 2027